π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Open Label, Phase 1 study of CD19 t-haNK as a single agent and combination ...
Status
Active Not Recruiting
Location
FARMOVS
Start Date
2024-08-23
Trial ID
NCT06334991
Treatments Being Tested
The purpose of this study is: * to assess clinical efficacy of Subetta in ...
Status
Completed
Location
State Healthcare Institution of Moscow "Central research institute of gastroenterology" of Department of health care of Moscow
Start Date
2013-05-07
Trial ID
NCT01868646
The purpose of this study is: * to assess clinical efficacy of Subetta in ...
Status
Completed
Location
State Healthcare Institution of Moscow "Central research institute of gastroenterology" of Department of health care of Moscow
Start Date
2013-05-07
Trial ID
NCT01868594
This study capitalizes on an opportunity to formally evaluate local adaptat...
Status
Completed
Location
Oregon Social Learning Center
Start Date
2022-05-16
Trial ID
NCT05816421
Treatments Being Tested
Part A: To test the safety and tolerability of combination therapy with Nir...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-10-12
Trial ID
NCT03307785
Open-label, Phase 1 Study of CD19 t-haNK as a Single Agent and in Combinati...
Status
Recruiting
Location
Hoag Memorial Hospital
Start Date
2025-08-22
Trial ID
NCT05618925
Treatments Being Tested